Two new studies presented at the American Academy of Neurology offered new insight on a two different pharamceutical treatments for RLS. To check out the studies, click on the links below:
Sleep Disturbance Reduced for Patients with Restless Legs Syndrome taking Pramipexole: Presented at AAN
Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
To read more announcements on what is going on in the world of RLS, make sure to visit our Announcements page each day.
Sunday, April 20, 2008
American Academy of Neurology News
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment